Literature DB >> 16688815

Remission of primary low-grade gastric lymphomas of the mucosa-associated lymphoid tissue type in immunocompromised pediatric patients.

Yasuharu Ohno1, Taichirou Kosaka, Izumi Muraoka, Takashi Kanematsu, Akira Tsuru, Eiichi Kinoshita, Hiroyuki Moriuchi.   

Abstract

We report the remission of primary gastric lymphoma of the mucosa-associated lymphoid tissue (MALT) type in two immunocompromised pediatric patients. Patient 1, a 14-year-old boy in an immunocompromised state of unknown cause, complained of repeated abdominal pain. Examinations revealed gastric MALT with local invasion and lymph node involvement. Serum anti-Helicobacter pylori (H pylori) antibody was positive. H pylori eradication was abandoned due to its adverse effects. The MALT lesion spontaneously regressed over the next 24 months without any treatment for lymphoma. Patient 2, a 6-year-old boy, underwent cord blood transplantation for the treatment of adrenoleukodystrophy. He was administered immunosuppressants for graft-versus-host disease after transplantation. Nausea and hematochezia appeared and further examinations revealed gastric MALT with H pylori gastritis. Treatment consisting of medication for the H pylori infection alone eradicated the H pylori and completely resolved the patient's MALT lesion, as well. Patients 1 and 2 were followed up over periods of 10 years and 3 years, respectively, without any signs of relapse. In conclusion, gastric lymphoma of the MALT type can be cured by conservative treatment even in immunocompromised pediatric patients.

Entities:  

Mesh:

Year:  2006        PMID: 16688815      PMCID: PMC4088002          DOI: 10.3748/wjg.v12.i16.2625

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  Regression of gastric lymphoma of mucosa associated with lymphoid tissue (MALT) following cardiac transplantation.

Authors:  P Boissonnat; Y El Bekkali; G Salles; J Dumortier; A Roussoulieres; L Sebbag; J Gare; J Robin; J Ninet; O Bastien
Journal:  J Heart Lung Transplant       Date:  2002-09       Impact factor: 10.247

2.  Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma.

Authors:  A C Wotherspoon; C Ortiz-Hidalgo; M R Falzon; P G Isaacson
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

Review 3.  Helicobacter pylori infection in children.

Authors:  B D Gold
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2001-09

4.  Helicobacter pylori-associated gastric MALT lymphoma in liver transplant recipients.

Authors:  T M Shehab; E D Hsi; J J Poterucha; N T Gunaratnam; R J Fontana
Journal:  Transplantation       Date:  2001-04-27       Impact factor: 4.939

Review 5.  Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.

Authors:  P Malfertheiner; F Mégraud; C O'Morain; A P S Hungin; R Jones; A Axon; D Y Graham; G Tytgat
Journal:  Aliment Pharmacol Ther       Date:  2002-02       Impact factor: 8.171

Review 6.  Helicobacter and gastric MALT lymphoma.

Authors:  M Stolte; E Bayerdörffer; A Morgner; B Alpen; T Wündisch; C Thiede; A Neubauer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

7.  Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.

Authors:  Michaël Levy; Christiane Copie-Bergman; Catherine Traulle; Anne Lavergne-Slove; Nicole Brousse; Jean-François Flejou; A de Mascarel; François Hemery; Philippe Gaulard; Jean-Charles Delchier
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

8.  Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.

Authors:  W Fischbach; M-E Goebeler-Kolve; B Dragosics; A Greiner; M Stolte
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

9.  MALT Lymphoma in Children: Case Report and Review of the Literature.

Authors:  Jun Q Mo; Haytham Dimashkieh; Susan R Mallery; Steven H Swerdlow; Kevin E Bove
Journal:  Pediatr Dev Pathol       Date:  2004 Jul-Aug

10.  MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature.

Authors:  Meredith J Aull; Joseph F Buell; V R Peddi; Jennifer Trofe; Thomas M Beebe; Michael J Hanaway; Prabir Roy-Chaudhury; Rita R Alloway; M Roy First; E Steve Woodle
Journal:  Transplantation       Date:  2003-01-27       Impact factor: 4.939

View more
  6 in total

Review 1.  What do we know about benefits of H. pylori treatment in childhood?

Authors:  Mónica S Sierra; Emily V Hastings; Karen J Goodman
Journal:  Gut Microbes       Date:  2013-11-06

2.  Ileal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma with a Large-Cell Component That Regressed Spontaneously.

Authors:  Yohsuke Makino; Hidekazu Suzuki; Toshihiro Nishizawa; Kaori Kameyama; Tadakazu Hisamatsu; Hiroyuki Imaeda; Makio Mukai; Toshifumi Hibi
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

Review 3.  Consequences of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; Caterina Anania; John F Osborn; Flavia Ferraro; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

4.  New Diagnostic Strategies for Detection of Helicobacter pylori Infection in Pediatric Patients.

Authors:  Benjamin D Gold; Mark A Gilger; Steven J Czinn
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-12

5.  Childhood cancers: what is a possible role of infectious agents?

Authors:  Kenneth Alibek; Assel Mussabekova; Ainur Kakpenova; Assem Duisembekova; Yeldar Baiken; Bauyrzhan Aituov; Nargis Karatayeva; Samal Zhussupbekova
Journal:  Infect Agent Cancer       Date:  2013-12-10       Impact factor: 2.965

6.  The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.

Authors:  Seiichi Kato; Toshiaki Shimizu; Shigeru Toyoda; Benjamin D Gold; Shinobu Ida; Takashi Ishige; Shigeru Fujimura; Shigeru Kamiya; Mutsuko Konno; Kentaro Kuwabara; Kosuke Ushijima; Norikazu Yoshimura; Yoshiko Nakayama
Journal:  Pediatr Int       Date:  2020-12       Impact factor: 1.524

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.